Formation of the Board of Directors of the Egyptian Drug Authority
His Excellency President Abdel Fattah El-Sisi issued Republican Decree No. 28 of 2026 on January 12, 2026, regarding the reconstitution of the Board of Directors of the Egyptian Drug Authority. The Board shall be chaired by Dr. Ali Mohammad Abd Al-Salam Al-Ghamrawy (with the rank of Minister), with Dr. Tamer Mohammad Ahmad Elhusseiny as Vice Chairman (with the rank of Deputy Minister), and the membership of:
-
Minister of Health and Population.
-
Minister of Industry.
-
Minister of Investment and Foreign Trade.
-
Chairman of the Board of Directors of the Egyptian Authority for Unified Procurement.
-
Chairman of the General Authority for Healthcare Accreditation and Regulation.
-
A Head of a Sector within the Authority, selected by the Chairman of the Board.
-
An academic member from the Faculties of Pharmacy with experience in the Authority's field of work, selected by the Prime Minister.
-
Two members with experience in the Authority's field of work, selected by the Prime Minister based on the nomination of the Chairman of the Authority's Board of Directors.
-
A representative of the Union of Medical Professions Syndicates.
-
A representative of civil society organizations with experience in the Authority's field of work, selected by the Prime Minister.
The Board of Directors may invite any experts or specialists deemed necessary to attend board meetings, without having a counted vote in the deliberations.
The term of membership in the Board of Directors shall be one year, effective from January 12, 2026.